JOSD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.481600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.944200E-01
Normal-vs-Stage2
6.629400E-01
Normal-vs-Stage3
6.829600E-01
Normal-vs-Stage4
5.116200E-01
Stage1-vs-Stage2
7.665400E-01
Stage1-vs-Stage3
4.163000E-01
Stage1-vs-Stage4
5.206400E-01
Stage2-vs-Stage3
2.738600E-01
Stage2-vs-Stage4
7.109800E-01
Stage3-vs-Stage4
2.915800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.733200E-01
Normal-vs-AfricanAmerican
9.588400E-01
Normal-vs-Asian
2.843600E-01
Caucasian-vs-AfricanAmerican
6.157400E-01
Caucasian-vs-Asian
9.963500E-02
AfricanAmerican-vs-Asian
1.550380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.784000E-01
Normal-vs-Female
6.232800E-01
Male-vs-Female
9.460000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.366400E-01
Normal-vs-Age(41-60Yrs)
6.649000E-01
Normal-vs-Age(61-80Yrs)
6.878600E-01
Normal-vs-Age(81-100Yrs)
4.062800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.609000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.580400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.392800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.177600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.378600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.143600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.152600E-01
Normal-vs-Daily Drinker
3.478200E-01
Normal-vs-Weekly Drinker
3.315800E-01
Normal-vs-Occasional Drinker
5.594000E-01
Normal-vs-Social Drinker
9.099600E-01
Non Drinker-vs-Daily Drinker
5.626500E-02
Non Drinker-vs-Weekly Drinker
1.113590E-01
Non Drinker-vs-Occasional Drinker
3.851400E-01
Non Drinker-vs-Social Drinker
7.090600E-01
Daily Drinker-vs-Weekly Drinker
8.683000E-01
Daily Drinker-vs-Occasional Drinker
3.736600E-01
Daily Drinker-vs-Social Drinker
8.044200E-02
Weekly Drinker-vs-Occasional Drinker
4.836600E-01
Weekly Drinker-vs-Social Drinker
9.870100E-02
Occasional Drinker-vs-Social Drinker
3.371000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.718800E-01
Normal-vs-Grade 2
8.333000E-01
Normal-vs-Grade 3
7.634200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.801430E-01
Grade 1-vs-Grade 3
1.398590E-01
Grade 1-vs-Grade 4
8.718800E-01
Grade 2-vs-Grade 3
6.639600E-01
Grade 2-vs-Grade 4
8.333000E-01
Grade 3-vs-Grade 4
7.634200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.414200E-01
Normal-vs-NonDiabetic
4.798200E-01
Diabetic-vs-NonDiabetic
7.665800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.367000E-01
Normal-vs-NoPancreatitis
5.884200E-01
Pancreatitis-vs-NoPancreatitis
3.235000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.356800E-01
Normal-vs-N1
6.807400E-01
N0-vs-N1
6.239000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.431800E-01
Normal-vs-TP53-NonMutant
6.019200E-01
TP53-Mutant-vs-TP53-NonMutant
1.723920E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
